OQS
IMVT icon

Occudo Quantitative Strategies’s Immunovant IMVT Stock Holding History

Occudo Quantitative Strategies’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-34,731
Closed -$860K – 771
2024
Q4 		$860K Buy
+34,731
New +$985K 0.16% 198
2022
Q1 		– Sell
-24,427
Closed -$208K – 1222
2021
Q4 		$208K Sell
24,427
-6,984
-22% -$57.7K 0.02% 882
2021
Q3 		$273K Buy
+31,411
New +$283K 0.03% 761
2021
Q2 		– Sell
-25,254
Closed -$405K – 961
2021
Q1 		$405K Buy
+25,254
New +$666K 0.09% 397

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
AGM
Alpine Global Management New York $668M AUM 20.22% 1-Year Est. Return

Occudo Quantitative Strategies's IMVT Position: Q1 2025 in Review

Occudo Quantitative Strategies sold out of Immunovant (IMVT) in Q1 2025, closing a stake of 34,731 shares — an estimated $860K sold.

Occudo Quantitative Strategies first reported a position in IMVT in Q1 2021 and held it in 4 quarters. The position peaked at $860K in Q4 2024. 193 funds tracked by Wall St. Rank hold IMVT as of Q1 2025.

  • Occudo Quantitative Strategies reported no remaining Immunovant position as of Q1 2025 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 34,731 Immunovant shares in Q1 2025, an estimated $860K.
  • Occudo Quantitative Strategies first reported a position in Immunovant in Q1 2021 and held it in 4 quarters.
  • Occudo Quantitative Strategies's Immunovant position peaked at $860K in Q4 2024.
  • 193 funds tracked by Wall St. Rank held Immunovant as of Q1 2025.

Based on Occudo Quantitative Strategies's 13F filing for Q1 2025, filed 15 May 2025.